iNtRON Biotechnology, Inc. (KOSDAQ:048530)
3,070.00
-25.00 (-0.81%)
May 20, 2026, 3:30 PM KST
-21.38% (1Y)
| Market Cap | 97.05B -26.4% |
| Revenue (ttm) | 5.74B -10.6% |
| Net Income | -8.96B |
| EPS | -282.94 |
| Shares Out | 31.61M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 104,708 |
| Average Volume | 210,575 |
| Open | 3,185.00 |
| Previous Close | 3,095.00 |
| Day's Range | 2,995.00 - 3,195.00 |
| 52-Week Range | 2,895.00 - 7,010.00 |
| Beta | n/a |
| RSI | 26.49 |
| Earnings Date | Mar 27, 2026 |